Recurrent Pregnancy Loss Treatment in Mumbai
At a Glance:
Definition: Two or more consecutive clinical pregnancy losses before 20 weeks
Affects: 1–2% of couples trying to conceive
Treatable cause identified in: Up to 50–75% of investigated cases
IVF with PGT-A: Reduces miscarriage risk by transferring only chromosomally normal embryos
Losing a pregnancy once is devastating. Losing two, three, or more is a grief that compounds with each cycle of hope and loss — and it raises an urgent, consuming question: why does this keep happening?
Recurrent pregnancy loss (RPL) — defined as two or more consecutive miscarriages — is not simply bad luck. In the majority of cases, there is an identifiable medical cause. And when that cause is found, it can usually be treated. The difficulty is that most couples are told to ‘keep trying’ after a first or second loss, without the structured investigation that could have changed the outcome far sooner.
This guide walks you through what recurrent miscarriage actually involves — the causes your specialist is looking for, the tests that uncover them, and the treatment pathways that have helped thousands of couples at FertilTree in Mumbai move from repeated loss to a sustained pregnancy.
What Is Recurrent Pregnancy Loss?
Medically, recurrent pregnancy loss refers to two or more failed clinical pregnancies, confirmed by ultrasound or histopathology — not just positive pregnancy tests that didn’t progress. The distinction matters: a chemical pregnancy (a briefly positive test followed by bleeding) and a confirmed first-trimester loss at 8 weeks involve different biology, different risk factors, and potentially different investigations.
Most RPL occurs in the first trimester. Losses beyond 12–14 weeks are less common but often point to specific structural or clotting-related causes that demand a different diagnostic approach. If you’ve experienced losses at different gestational ages, bring your full history — dates, scan reports, any tissue analysis — to your first consultation. Every detail helps narrow the investigation.
Why Do Recurrent Miscarriages Happen? The Major Causes
No single factor explains every case of RPL. The causes fall into five broad categories — and in many patients, more than one factor is contributing simultaneously.
Chromosomal and Genetic Factors
Chromosomal abnormalities in the embryo are the single most common cause of miscarriage at any stage, responsible for roughly 50–60% of first-trimester losses. In RPL specifically, either the embryo carries a random chromosomal error (aneuploidy), or one partner carries a balanced translocation — a structural rearrangement of chromosomes that doesn’t affect the carrier but creates unbalanced embryos. A simple blood test (karyotyping) for both partners can identify translocations. Where embryo aneuploidy is suspected, Preimplantation Genetic Testing (PGT) during an IVF cycle allows only chromosomally normal embryos to be transferred — directly reducing the risk of another loss.
Uterine Structural Abnormalities
A septate uterus, large submucosal fibroids, intrauterine adhesions (Asherman’s syndrome), or cervical incompetence can all prevent a pregnancy from implanting securely or growing to viability. Many of these are correctable through minimally invasive surgery. If fibroids are a concern, understanding how an intramural fibroid affects fertility is useful context. Your specialist will arrange a detailed uterine evaluation as part of the RPL workup — a core component of female fertility testing in Mumbai at FertilTree.
Hormonal and Endocrine Disorders
Uncontrolled thyroid dysfunction, poorly managed diabetes, elevated prolactin, and luteal phase deficiency (insufficient progesterone after ovulation) are all associated with pregnancy loss. Polycystic ovarian syndrome (PCOS) also carries an elevated miscarriage risk, partly related to insulin resistance and hormonal imbalance. FertilTree’s PCOS treatment programme in Mumbai addresses these metabolic factors as part of comprehensive fertility management.
Blood Clotting and Immune-Related Causes
Antiphospholipid syndrome (APS) is the most well-established immune cause of RPL. It triggers abnormal blood clotting in the tiny placental vessels, starving the pregnancy of blood supply. APS is diagnosed through specific antibody tests (lupus anticoagulant, anticardiolipin, anti-beta2 glycoprotein) and is treatable with low-dose aspirin and heparin injections during pregnancy. Inherited thrombophilias — such as Factor V Leiden or prothrombin gene mutations — may also contribute, particularly in second-trimester losses.
Unexplained Recurrent Pregnancy Loss
Even after comprehensive testing, roughly 25–50% of RPL cases have no identifiable cause. This is genuinely frustrating — but it’s not a dead end. Unexplained RPL actually carries the best prognosis for future pregnancy, with supportive care and close monitoring resulting in successful outcomes in 60–75% of subsequent pregnancies. Sometimes, the most evidence-based treatment is structured support, early pregnancy scans, and progesterone supplementation — not a more invasive intervention.
How Is Recurrent Pregnancy Loss Diagnosed?
A thorough RPL investigation isn’t a single blood test — it’s a structured diagnostic panel covering genetics, anatomy, hormones, and clotting. At FertilTree, the following workup is standard for couples presenting with two or more losses:
Category | Tests Performed | What It Identifies |
Genetic | Parental karyotyping; products of conception (POC) chromosomal analysis | Balanced translocations; embryo aneuploidy patterns |
Anatomical | 3D pelvic ultrasound; hysteroscopy; sonohysterography (SIS) | Septate uterus, fibroids, adhesions, cervical issues |
Hormonal | TSH, prolactin, fasting insulin, progesterone (Day 21), AMH | Thyroid disease, PCOS, luteal phase deficiency, ovarian reserve |
Thrombophilia / Immune | Lupus anticoagulant, anticardiolipin, anti-beta2 GP1, Factor V Leiden, prothrombin mutation | Antiphospholipid syndrome; inherited clotting disorders |
Male Factor | Semen analysis; sperm DNA fragmentation | Elevated sperm DNA damage contributing to embryo failure |
Sperm DNA fragmentation testing is increasingly recognised as an important part of the RPL picture. High DNA damage in sperm can contribute to poor embryo development and early pregnancy loss, even when standard parameters appear normal. If male factor issues are suspected, FertilTree’s male infertility specialist in Mumbai provides the full investigative workup alongside your RPL evaluation.
Treatment Options for Recurrent Miscarriage at FertilTree
Treatment is always cause-specific. There is no universal protocol for RPL — the right intervention depends entirely on what your diagnostic workup reveals.
Genetic Screening and IVF with PGT-A
For couples where chromosomal abnormalities are driving the losses, IVF combined with PGT-A (preimplantation genetic testing for aneuploidies) is the most direct solution. Embryos are created, cultured to blastocyst stage, biopsied, and screened. Only chromosomally normal embryos are transferred — dramatically reducing the risk of another miscarriage. FertilTree’s dedicated genetics and PGT laboratory supports this entire process under one roof.
Surgical Corrections
A uterine septum can be resected hysteroscopically. Submucosal fibroids distorting the uterine cavity are removed before conception is attempted. Cervical cerclage — a stitch placed at the cervix during early pregnancy — is effective for patients with confirmed cervical incompetence causing second-trimester losses. These are targeted procedures with well-documented improvements in pregnancy retention rates.
Hormonal and Metabolic Management
Thyroid correction, prolactin normalisation, insulin sensitisation for PCOS, and progesterone supplementation during early pregnancy are all evidence-based interventions. The key is identifying and treating the specific hormonal imbalance before the next pregnancy begins — not during it. For patients with endometriosis-related RPL, our endometriosis specialist programme in Mumbai integrates surgical and medical management with fertility planning.
Anticoagulant and Immune Therapy
For antiphospholipid syndrome, the standard treatment is a combination of low-dose aspirin (started before conception) and heparin injections (started at positive pregnancy test). This protocol has transformed APS from a condition associated with near-certain loss to one with a 70–80% live birth rate under specialist care. Inherited thrombophilias may also warrant anticoagulant support, assessed on a case-by-case basis.
When IVF Becomes the Right Path After Recurrent Loss
IVF is not the first-line treatment for every RPL patient. But it becomes the clearest route to a successful pregnancy in several situations: when parental chromosomal translocation is confirmed, when age-related aneuploidy is the likely driver, when multiple causes coexist, or when natural conception has repeatedly ended in loss despite treating identified factors. Research consistently shows that age has a measurable impact on IVF outcomes, which is why RPL patients over 35 are often advised to consider this route sooner.
Why RPL Patients Choose Dr. Firuza Parikh and FertilTree
Managing recurrent pregnancy loss requires a specialist who has seen enough cases to recognise rare patterns and enough outcomes to know which interventions actually change results. Dr. Firuza Parikh brings that depth. As the clinical head of Jaslok-FertilTree International Fertility Centre in Mumbai, she has spent over three decades treating couples with complex reproductive histories — including hundreds of RPL cases where standard approaches elsewhere had failed.
Her medical training began at KEM Hospital and Seth G.S. Medical College, where she completed her MD and national board qualification with top honours across multiple disciplines. Advanced fellowship training in the UK and US followed, with specific exposure to reproductive immunology, recurrent loss investigation, and embryo genetics — the three pillars that define modern RPL management.
What distinguishes her RPL practice specifically:
- Deep genetic testing capability — FertilTree has completed over 1,500 PGT cycles, including PGT-A for aneuploidy screening in recurrent loss couples and PGT-M for single-gene disorders. This volume means the laboratory team handles complex biopsy-freeze-test-transfer sequences routinely, not as rare exceptions.
- Documented outcomes that hold up to scrutiny — pregnancy rates of 38–42% per cycle and 47–51% per couple reflect real, audited numbers across the full patient mix, not cherry-picked cohorts. For RPL patients with identified and treated causes, individual prognosis is often substantially higher.
- Recognised clinical leadership — FertilTree has been rated the top-performing fertility centre in Mumbai across multiple independent national surveys conducted by the Times of India and Economic Times. Dr. Parikh’s personal accolades include over 40 professional honours spanning clinical innovation, public health impact, and scientific research.
- Pioneering genetic firsts relevant to RPL — her team delivered India’s first twins confirmed free of the BRCA1 mutation through preimplantation testing, and performed South-East Asia’s first successful PGT for Robertsonian translocation — a chromosomal rearrangement that is one of the most common genetic causes of recurrent miscarriage.
As one of Mumbai’s most established IVF centres, FertilTree’s approach to recurrent pregnancy loss is built on the same investigative rigour and laboratory precision that defines every treatment programme at the centre. Over 20,000 families have been built through this system across three decades of continuous practice.
Frequently Asked Questions: Recurrent Pregnancy Loss
Q1: How many miscarriages qualify as recurrent pregnancy loss?
Most international guidelines define RPL as two or more consecutive clinical pregnancy losses. Some older definitions required three, but current evidence supports beginning investigation after two losses — especially in women over 35 where time is a clinical factor.
Q2: Can recurrent miscarriage be treated successfully?
Yes. When a specific cause is identified — hormonal, anatomical, genetic, or clotting-related — targeted treatment significantly improves the chance of a successful pregnancy. Even in unexplained RPL, supportive care results in a live birth in 60–75% of subsequent pregnancies.
Q3: Is IVF always needed after recurrent miscarriage?
No. Many RPL causes are treatable without IVF — thyroid correction, APS treatment with aspirin and heparin, or surgical removal of a uterine septum. IVF with PGT becomes the recommended path specifically when chromosomal factors are driving the losses or when multiple other treatments have not prevented further miscarriage.
Q4: Does age affect the risk of recurrent miscarriage?
Significantly. The risk of chromosomally abnormal embryos increases with maternal age, particularly after 35. This is why PGT-A during IVF is especially relevant for older patients with RPL — it allows screening for aneuploidy before transfer rather than discovering it through another loss.
Q5: Should my partner also be tested?
Absolutely. Parental karyotyping for both partners is standard in any RPL investigation. Sperm DNA fragmentation testing is also increasingly recommended, as elevated DNA damage in sperm can contribute to embryo failure and early miscarriage even when routine semen parameters appear normal.
Q6: What is the cost of RPL investigation and treatment at FertilTree?
The investigation phase includes blood tests, imaging, and genetic screening — costs vary depending on which tests are clinically indicated. If IVF with PGT is recommended, the IVF treatment cost page provides a transparent breakdown. FertilTree shares all costs at your initial consultation with no hidden charges.
